FDA Inspection
Charles River Laboratories, Inc.Charles River Laboratories, Inc. – FDA Inspection, Jun 21, 2017
Record Details
This FDA Inspection record concerns Charles River Laboratories, Inc., with an inspection on June 21, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3b89e813-1c88-4984-a5e3-3804147c227a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1015411
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.22(b)Adequate lab facilities not available
- 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
- 21 CFR 211.160(a)Lab controls established, including changes
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Charles River Laboratories, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 9, 2025 | VAI | New England District Office | Drug Quality Assurance |
| May 2, 2025 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 11, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 12, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Charles River Laboratories, Inc.
- FDA Inspection 1281548 - 2025-09-09
- FDA Inspection 1271053 - 2025-05-02
- FDA Inspection 1118068 - 2020-02-11
- FDA Inspection 889473 - 2014-06-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.